Frontlight ResearchEarly access
Trial site
Bürgerspital Solothurn
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Osteoarthritis2 trials
- Osteonecrosis (avascular necrosis)2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Lung cancer1 trial
- Neuroendocrine tumours1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 21 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Medacta International SA2 trials
- ETOP IBCSG Partners Foundation1 trial
- Insel Gruppe AG, University Hospital Bern1 trial
- Swiss Cancer Institute1 trial
- University Hospital, Basel, Switzerland1 trial
Running trials
Recruiting
Recruiting
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
Active, not recruiting
Active, not recruiting
Recruiting
The Medacta International SMS Post-Marketing Surveillance Study
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Osteoarthritis1 recruiting
- Osteonecrosis (avascular necrosis)1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026